BGPT: Author Review: Carmit Levy

Explore by Goal

Quick Explanation Copied

Carmit Levy — scientific-impact snapshot (evidence-based, skeptical)

Based on the provided OpenAlex author record: 125 works, ~5088 citations, and h-index 36 with a long publication tail and multiple highly cited work items (e.g., MITF review; intronic miR-211 study). This is impact/visibility evidence, not proof of experimental rigor or reproducibility.

Long Explanation

Author Review: Carmit Levy

Scope: scientific strength review using only the information included in your prompt (OpenAlex metrics + the listed “top works”).
Epistemic humility: citation metrics indicate influence/visibility, but they do not directly measure data quality, experimental design rigor, or reproducibility.

Today: Mar 30, 2026

VISUALIZE FIRST (impact & tempo)

The figures below use the exact “counts_by_year” numbers provided in your OpenAlex snippet.

Key author-level metrics from the provided record

Works: 125
Cited by: 5088
h-index: 36
ORCID (provided): https://orcid.org/0000-0003-2683-8779

Skeptical note: h-index and citation totals are proxies for influence and persistence; they can be affected by field size, citation practices, and historical longevity of topics.

VISUALIZE FIRST (top cited works, by citation count)

Below are the “top_works” items explicitly included in your prompt. Citation counts come from that same snippet.

Explaining second (critical scientific strength review)

1) What is “known” from your provided data

The provided OpenAlex snippet indicates the author has 125 works, h-index 36, and 5088 citations.
The snippet lists multiple highly cited biology/medicine/cancer-relevant items (including a Trends/Review-style entry on MITF and several mechanistic studies involving microRNAs, transcription factors, chromatin/DNA methylation, and related regulatory axes).
The record includes a long publication history (spanning multiple decades) and a recent surge in works count for 2023 (24 works in that year, per snippet).

2) Scientific strength signals (evidence-weighted, but still skeptical)

Influence consistency across topics: citation-heavy items suggest the work entered ongoing research threads (e.g., transcription-factor regulation frameworks; microRNA biology; tumor microenvironment / stromal cell heterogeneity; DNA methylation–linked miRNA biogenesis). However, without full-text method details, we cannot infer rigor, sample sizes, controls, or reproducibility from citation counts alone.
Multiple high-impact venues implied: the prompt lists papers spanning major journals (reviews and mechanistic articles). This can correlate with methodological standards, but cannot substitute for reading the experiments and statistical designs.
Mechanistic specificity: several listed titles strongly suggest mechanistic regulation studies (TF–miRNA axes, intronic miRNA function, DNA methylation directing miRNA biogenesis, DICER regulation). Mechanistic work is often harder to “land” via broad correlation alone, but the snippet still does not provide whether claims were supported with orthogonal validation (e.g., genetic perturbations, rescue experiments, blinding/replication strategy).

3) Likely biological domains (from topic tags in the snippet)

The snippet’s topic scores emphasize Biology and Medicine, with substantial Genetics and Cancer research weight.

4) Counterpoints / blind spots (what we cannot verify here)

Rigor cannot be directly assessed from the provided snippet: we do not have replication counts, statistical power, blinding practices, raw data availability, model system validity, or whether conclusions were revised as the field evolved.
Publication bias & citation lag: highly cited review articles can inflate perceived author “experimental” impact even if later mechanistic studies were more uncertain. Citation histories can also favor topics that were prominent during specific eras.
Reproducibility risk: citation totals do not tell us whether key results generalized across labs, cell types, or experimental modalities.
Selection bias in “top works” list: only a subset is shown; absence of low- or mixed-result papers does not mean they do not exist.

5) Bottom-line scientific evaluation (with explicit confidence)

Best-supported claim from this prompt: Carmit Levy demonstrates high scholarly influence (proxy: h-index 36; 5088 cited-by; multiple top cited works listed).
Not directly supported by this prompt: the degree of experimental rigor, transparency, and reproducibility across the body of work.
Confidence: high for impact/visibility claims tied to the snippet; low-to-moderate for any deeper claims about biological correctness, method quality, or reproducibility.

Quick structured table (from provided “top_works” items)

This table is built from the specific work entries included in your prompt.

Year	Type	Title (truncated)	Cited by (as provided)	DOI
2006	review	MITF: master regulator of melanocyte development and melanoma oncogene	1145	10.1016/j.molmed.2006.07.008
2010	article	Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma	277	10.1016/j.molcel.2010.11.020
2018	article	Bone marrow–derived fibroblasts are a functionally distinct stromal cell population in breast cancer	257	10.1084/jem.20180818
2021	review	Melanoma models for the next generation of therapies	223	10.1016/j.ccell.2021.01.011
2016	article	Melanoma miRNA trafficking controls tumour primary niche formation	203	10.1038/ncb3399
2015	article	A widespread role of the motif environment in transcription factor binding across diverse protein families	166	10.1101/gr.184671.114
2004	article	Sumoylation of MITF and Its Related Family Members TFE3 and TFEB	146	10.1074/jbc.m411757200
2010	article	Lineage-Specific Transcriptional Regulation of DICER by MITF in Melanocytes	124	10.1016/j.cell.2010.05.004
2013	article	Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1	123	10.1038/jid.2013.340
2019	article	DNA methylation directs microRNA biogenesis in mammalian cells	121	10.1038/s41467-019-13527-1

Most useful next step (for real rigor assessment)

To evaluate scientific rigor (not just citation influence), the missing data is: full-text methods, statistical analysis plan details, raw/processed data availability, and whether conclusions remain after later replication/updates.

Feedback:

Updated: March 30, 2026